(Q89291085)

English

Myocarditis as an immune-related adverse event with ipilimumab/nivolumab combination therapy for metastatic melanoma

scientific article published on 01 June 2016

Statements

Myocarditis as an immune-related adverse event with ipilimumab/nivolumab combination therapy for metastatic melanoma (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit